Dr. Elaine Abrams is a member of ICAP’s senior leadership team, a Professor of Pediatrics and Epidemiology at Columbia University, and an internationally recognized expert with 20 years of experience in HIV-related programming and research. She has been deeply involved in ICAP’s PEPFAR-funded work supporting the global scale up of HIV services to adults, children and pregnant and lactating women and has led several of the most innovative initiatives in PMTCT and pediatrics at ICAP including the development of centers of excellence in multiple countries for PMTCT and pediatrics; product development (Positive Voices, EID Manual, PMTCT toolkit); and the introduction of routine HIV testing of hospitalized pediatric patients. Dr. Abrams currently serves as the Principal Investigator of the current PEPFAR-funded Global Technical Assistance (TA) award, which has provided wide-ranging TA through 48 projects across 23 countries. She is also responsible for a growing agenda of operational research studies of HIV prevention, care, and treatment programs supported through ICAP programs in Africa and leads an independent portfolio of research studies optimizing approaches to pediatric treatment and perinatal prevention. Dr. Abrams has been deeply involved in the development of international, national, and local guidelines and policies for HIV prevention, care, and treatment, and chaired the WHO 2015, 2018, and 2019 Clinical Guidelines Groups, which introduced Option B+, Test and Start, dolutegravir, and ARVs for prevention. Dr. Abrams holds an MD from the Columbia University College of Physicians and Surgeons.